Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 867 Records) |
Query Trace: JAK2[original query] |
---|
Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 2023 12 . Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stéphane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benaji |
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
[Etiological analysis of a patient with multiple primary malignant neoplasms]. Zhonghua yi xue za zhi 2023 12 103 (47): 3848-3851. P J Shi, Y B Li, H P Xi |
JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
JAK2V617F Mutation and Associated Chromosomal Alterations in Primary and Secondary Myelofibrosis and Post-HCT Outcomes. Blood advances 2023 11 . Maryam Rafati, Derek Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadal |
Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms. Internal medicine (Tokyo, Japan) 2023 11 . Hiroki Hosoi, Yoshikazu Hori, Katsuhiro Fukutsuka, Mitsuo Osuga, Yasuhiro Koh, Toshiki Mushino, Nobuyoshi Hanaoka, Nobuyuki Yamamoto, Hitoshi Ohno, Takashi Sono |
Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil. Biomedical reports 2023 11 19 (6): 98. Dania G Torres, Emanuela V Barbosa Alves, Miliane Araújo de Sousa, Wanessa H Laranjeira, Jhemerson Paes, Erycka Alves, Deborah Canté, Allyson G Costa, Adriana Malheiro, Rosângela Abreu, Leny Nascimento, Nelson A Fraiji, George A V Silva, Lucivana P de Souza Mourão, Andréa M Tarra |
Associations of A20, CYLD, Cezanne and JAK2 Genes and Immunophenotype with Psoriasis Susceptibility. Medicina (Kaunas, Lithuania) 2023 10 59 (10): . Nguyen Hoang Giang, Nguyen Thi Kim Lien, Do Thi Trang, Pham Thi Huong, Nguyen Huy Hoang, Nguyen Thi Xu |
Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients. Diseases (Basel, Switzerland) 2023 10 11 (4): . Rafael Saperstein, Sanjay Goel, Radhashree Mait |
Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
Determinants of mosaic chromosomal alteration fitness. Nature communications 2024 5 15 (1): 3800. Yash Pershad, Taralynn Mack, Hannah Poisner, Yasminka A Jakubek, Adrienne M Stilp, Braxton D Mitchell, Joshua P Lewis, Eric Boerwinkle, Ruth J F Loos, Nathalie Chami, Zhe Wang, Kathleen Barnes, Nathan Pankratz, Myriam Fornage, Susan Redline, Bruce M Psaty, Joshua C Bis, Ali Shojaie, Edwin K Silverman, Michael H Cho, Jeong H Yun, Dawn DeMeo, Daniel Levy, Andrew D Johnson, Rasika A Mathias, Margaret A Taub, Donna Arnett, Kari E North, Laura M Raffield, April P Carson, Margaret F Doyle, Stephen S Rich, Jerome I Rotter, Xiuqing Guo, Nancy J Cox, Dan M Roden, Nora Franceschini, Pinkal Desai, Alex P Reiner, Paul L Auer, Paul A Scheet, Siddhartha Jaiswal, Joshua S Weinstock, Alexander G Bi |
BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience. International journal of molecular sciences 2024 5 25 (10): . Fei Fei, Caitlin Caporale, Lisa Chang, Barbara K Fortini, Haris Ali, Diana Bell, Anthony Stein, Guido Marcucci, Milhan Telatar, Michelle Afkha |
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia 2024 5 . Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei |
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. Molecular diagnosis & therapy 2024 4 . Youngeun Lee, Soo Hyun Seo, Jinho Kim, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Kyoung Un Park, Sang Mee Hwa |
Two Novel Genetic Variants Involved in the Oxygen Sensing Pathway in JAK2-unmutated Erythrocytosis. Biochemical genetics 2024 4 . Qiang Ma, Ronghua Hu, Wuhan Hui, Hong Zhao, Dongmei Zou, Yan Liu, Wanling S |
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms. Life (Basel, Switzerland) 2024 4 14 (4): . Roberto Castelli, Alessandra Berzuini, Roberto Manetti, Alessandro Palmerio Delitala, Dante Castro, Giuseppe Sanna, Marta Chiara Sircana, Nicia Isabella Profili, Arianna Bartoli, Leyla La Cava, Giorgio Lambertenghi Deliliers, Mattia Donadoni, Antonio Gida |
A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 2024 4 . Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinbe |
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology 2024 4 . Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An H |
Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients. Scientific reports 2024 4 14 (1): 9389. Jhemerson F Paes, Dania G Torres, Deborah C Aquino, Emanuela V B Alves, Erycka A Mesquita, Miliane A Sousa, Nelson Abrahim Fraiji, Leny N M Passos, Rosângela S Abreu, George A V Silva, Andréa M Tarragô, Lucivana P de Souza Mour |
Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR. Cancer medicine 2024 4 13 (7): e7123. Zhanlong Wang, Xin Tian, Jinyu Ma, Yuhui Zhang, Wenru Ta, Yifan Duan, Fengli Li, Hong Zhang, Long Chen, Shaobin Yang, Enbin Liu, Yani Lin, Weiping Yuan, Kun Ru, Jie B |
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database. International journal of cardiology. Heart & vasculature 2024 1 49 101304. Orly Leiva, Jose Alvarez-Cardona, Joan How, Andrew Brunner, Gabriela Hob |
Abdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing-A prevalence study of patients in Mecklenburg-West Pomerania (2017-2021). Frontiers in medicine 2024 1 10 1344769. Larissa Henze, Luise Grunwald, Sabine Felser, Maria Witte, Christina Grosse-Thie, Catrin Roolf, Hugo Murua Escobar, Christian Junghan |
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Annals of hematology 2024 1 . Marta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes, Alberto Alvarez-Larr |
Idiopathic erythrocytosis: a germline disease? Clinical and experimental medicine 2024 1 24 (1): 11. E M Elli, M Mauri, D D'Aliberti, I Crespiatico, D Fontana, S Redaelli, S Pelucchi, S Spinelli, B Manghisi, F Cavalca, A Aroldi, A Ripamonti, S Ferrari, S Palamini, F Mottadelli, L Massimino, D Ramazzotti, G Cazzaniga, A Piperno, C Gambacorti-Passerini, R Piaz |
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood cancer journal 2024 1 14 (1): 6. Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander J Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina Snider, Andrew Sochacki, Dixon Dorand, Taralynn M Mack, P Brent Ferrell, Yaomin Xu, Cosmin A Bejan, Michael R Savona, Alexander G Bi |
Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients. Hematology (Amsterdam, Netherlands) 2024 1 29 (1): 2297597. Christopher Puli'uvea, Tracey Immanuel, Taryn N Green, Peter Tsai, Peter R Shepherd, Maggie L Kalev-Zylins |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 28, 2024
- Content source: